Spectrezine has received this communication from US-based Avaaz, which is campaigning to keep the Internet free of corporate control, a campaign which we fully support.
Odd to find oneself in even partial agreement with US ratings agency Standard & Poor's (S&P), one of the bodies which now determines government policy throughout most of the developed world, or at least has far greater influence on it than do the hapless voters.
I. The crisis of European imperialist integration The year 2011 (and as it seems today quite probably 2012 also) was marked by the crisis of one of the main international pillars of capitalism: the European Union (EU). What is usually described as a crisis of the Eurozone (strictly speaking the European Monetary Union – EMU) is in fact a crisis of the whole EU edifice system, of which EMU is its most avant-gardist structure.
The long-running corporate coup d’état being carried out in Europe has intensified with new treaty proposals that would impose a common EU austerity policy across the Eurozone.
The European ruling elite likes to pretend that the crisis afflicting the Eurozone countries was something both unforeseen and unforeseeable, the result of circumstances beyond its control deriving
The EU is today going through the worst crisis since its foundation. This crisis is part of a global financial, economic, social, ecological and political crisis, which is hitting people very hard, starting with women and young people, for whom the future is looking darker.
We are a radical journal of the European Left and welcome contributions on the whole range of subjects covered in our pages. Take a look at the category descriptions to see what we are looking for. Aside from the obvious exclusion of racist, sexist or otherwise offensive materials, Spectrezine will not publish sectarian attacks by one section of the movement against corporate capitalism on another. We don't believe anyone has all the answers, and are open to all sections of the radical left. Please feel free to address any questions concerning Spectrezine to the editor.
